RS49718B - Postupak dobijanja magnezijumove soli supstituisanog heterocikličnog sulfinila - Google Patents
Postupak dobijanja magnezijumove soli supstituisanog heterocikličnog sulfinilaInfo
- Publication number
- RS49718B RS49718B YUP-448/98A YU44898A RS49718B RS 49718 B RS49718 B RS 49718B YU 44898 A YU44898 A YU 44898A RS 49718 B RS49718 B RS 49718B
- Authority
- RS
- Serbia
- Prior art keywords
- alkyl
- hydrogen
- groups
- magnesium
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9601598A SE508669C2 (sv) | 1996-04-26 | 1996-04-26 | Nytt förfarande |
Publications (2)
Publication Number | Publication Date |
---|---|
YU44898A YU44898A (sh) | 1999-07-28 |
RS49718B true RS49718B (sr) | 2007-12-31 |
Family
ID=20402358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-448/98A RS49718B (sr) | 1996-04-26 | 1998-10-14 | Postupak dobijanja magnezijumove soli supstituisanog heterocikličnog sulfinila |
Country Status (40)
Country | Link |
---|---|
US (1) | US6124464A (sr) |
EP (1) | EP0897386B1 (sr) |
JP (1) | JP4233115B2 (sr) |
KR (1) | KR100468331B1 (sr) |
CN (1) | CN1100776C (sr) |
AR (1) | AR006640A1 (sr) |
AT (1) | ATE222904T1 (sr) |
BR (1) | BR9708829A (sr) |
CA (1) | CA2251636C (sr) |
CZ (1) | CZ295067B6 (sr) |
DE (1) | DE69714987T2 (sr) |
DK (1) | DK0897386T3 (sr) |
DZ (1) | DZ2209A1 (sr) |
EE (1) | EE03485B1 (sr) |
EG (1) | EG23874A (sr) |
ES (1) | ES2180981T3 (sr) |
HK (1) | HK1016978A1 (sr) |
HR (1) | HRP970210B1 (sr) |
HU (1) | HUP9901798A3 (sr) |
ID (1) | ID16685A (sr) |
IL (1) | IL126716A (sr) |
IS (1) | IS1984B (sr) |
MA (1) | MA24143A1 (sr) |
MY (1) | MY119011A (sr) |
NO (1) | NO318850B1 (sr) |
NZ (1) | NZ332154A (sr) |
PL (1) | PL188824B1 (sr) |
PT (1) | PT897386E (sr) |
RS (1) | RS49718B (sr) |
RU (1) | RU2163238C2 (sr) |
SA (1) | SA97170759B1 (sr) |
SE (1) | SE508669C2 (sr) |
SI (1) | SI0897386T1 (sr) |
SK (1) | SK282752B6 (sr) |
TN (1) | TNSN97068A1 (sr) |
TR (1) | TR199802156T2 (sr) |
TW (1) | TW420676B (sr) |
UA (1) | UA51699C2 (sr) |
WO (1) | WO1997041114A1 (sr) |
ZA (1) | ZA973153B (sr) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
US6875872B1 (en) * | 1993-05-28 | 2005-04-05 | Astrazeneca | Compounds |
US6699885B2 (en) | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
DE19843413C1 (de) | 1998-08-18 | 2000-03-30 | Byk Gulden Lomberg Chem Fab | Neue Salzform von Pantoprazol |
DK1131316T3 (da) * | 1998-11-18 | 2004-09-27 | Astrazeneca Ab | Forbedret kemisk fremgangsmåde og farmaceutisk præparat |
CA2290893C (en) * | 1999-11-16 | 2007-05-01 | Bernard Charles Sherman | Magnesium omeprazole |
JP5412023B2 (ja) * | 2000-08-04 | 2014-02-12 | 武田薬品工業株式会社 | ベンズイミダゾール化合物の塩およびその用途 |
US20040006111A1 (en) * | 2002-01-25 | 2004-01-08 | Kenneth Widder | Transmucosal delivery of proton pump inhibitors |
WO2003074514A1 (en) * | 2002-03-05 | 2003-09-12 | Astrazeneca Ab | Alkylammonium salts of omeprazole and esomeprazole |
DE10234617B4 (de) * | 2002-07-29 | 2013-04-04 | Nycomed Gmbh | Neues Salz von (S)-Pantoprazol |
TW200410955A (en) * | 2002-07-29 | 2004-07-01 | Altana Pharma Ag | Novel salt of (S)-PANTOPRAZOLE |
US20040235903A1 (en) * | 2002-10-22 | 2004-11-25 | Khanna Mahavir Singh | Amorphous form of esomeprazole salts |
WO2004046134A2 (en) * | 2002-11-18 | 2004-06-03 | Dr. Reddy's Laboratories Limited | Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation |
AU2003303240A1 (en) * | 2002-12-19 | 2004-07-14 | Eva Pharmaceutical Industries Ltd. | Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
EP1606279A1 (en) * | 2003-02-28 | 2005-12-21 | Ranbaxy Laboratories, Ltd. | Polymorphs of s-omeprazole |
PE20050150A1 (es) | 2003-05-08 | 2005-03-22 | Altana Pharma Ag | Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo |
CL2004000983A1 (es) | 2003-05-08 | 2005-03-04 | Altana Pharma Ag | Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y |
WO2005012289A1 (en) * | 2003-07-17 | 2005-02-10 | Altana Pharma Ag | Novel salt of (r) - pantoprazole |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
SE0302381D0 (sv) | 2003-09-04 | 2003-09-04 | Astrazeneca Ab | New salts I |
SE0302382D0 (sv) * | 2003-09-04 | 2003-09-04 | Astrazeneca Ab | New salts II |
ITMI20031813A1 (it) * | 2003-09-23 | 2005-03-24 | Dinamite Dipharma S P A In Forma A Bbreviata Diph | Procedimento per la preparazione di pantoprazolo e suoi sali. |
WO2005082888A1 (en) * | 2004-03-01 | 2005-09-09 | Milen Merkez Ilac Endustrisi A.S. | Process for the preparation of magnesium salt of omeprazole |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
ES2246149B1 (es) | 2004-07-02 | 2007-06-01 | Esteve Quimica, S.A. | Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion. |
US8779175B2 (en) * | 2004-10-25 | 2014-07-15 | Synthonics, Inc. | Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients |
US7799937B2 (en) | 2004-10-25 | 2010-09-21 | Synthonics, Inc. | Metal coordinated compositions |
US20060141054A1 (en) | 2004-10-25 | 2006-06-29 | Thomas Piccariello | Metal coordinated compositions |
EP1801110A1 (en) | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Esomeprazole arginine salt |
US7553857B2 (en) | 2005-12-23 | 2009-06-30 | Lek Pharmaceuticals D.D. | S-omeprazole magnesium |
US20080139623A1 (en) | 2006-06-12 | 2008-06-12 | Lilach Hedvati | Amorphous and crystalline forms of pantoprazole magnesium salt |
EP1947099A1 (en) * | 2007-01-18 | 2008-07-23 | LEK Pharmaceuticals D.D. | Process for solvent removal from omeprazole salts |
WO2008102145A2 (en) | 2007-02-21 | 2008-08-28 | Cipla Limited | Process for the preparation of esomeprazole magnesium dihydrate |
WO2009047775A2 (en) * | 2007-10-08 | 2009-04-16 | Hetero Drugs Limited | Polymorphs of esomeprazole salts |
EP2147918A1 (en) | 2008-07-21 | 2010-01-27 | LEK Pharmaceuticals D.D. | Process for the preparation of S-omeprazole magnesium in a stable form |
WO2010097583A1 (en) | 2009-02-24 | 2010-09-02 | Cipla Limited | Esomeprazole potassium polymorph and its preparation |
US20110207779A1 (en) * | 2010-02-25 | 2011-08-25 | Glenmark Generics Ltd | Process for the preparation of esomeprazole magnesium |
EP2426111A1 (en) | 2010-08-09 | 2012-03-07 | Laboratorios Del. Dr. Esteve, S.A. | 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms |
CN103467453A (zh) * | 2013-09-13 | 2013-12-25 | 上海海虹实业(集团)巢湖今辰药业有限公司 | 一种奥美拉唑镁原料药制备方法 |
CN106397399A (zh) * | 2015-07-29 | 2017-02-15 | 陕西合成药业股份有限公司 | 一种泮托拉唑镁的精制方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8301182D0 (sv) * | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
GB8307865D0 (en) * | 1983-03-22 | 1983-04-27 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives |
FI861772A (fi) * | 1985-05-07 | 1986-11-08 | Chemie Linz Ag | Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning. |
FI864138A (fi) * | 1985-10-16 | 1987-04-17 | Fisons Plc | Heterocykliska blandningar. |
WO1993006097A1 (en) * | 1991-09-20 | 1993-04-01 | Merck & Co., Inc. | Novel process for the preparation of anti-ulcer agents |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
SE9302396D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | A novel compound form |
SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
ATE206044T1 (de) * | 1994-07-08 | 2001-10-15 | Astrazeneca Ab | Aus mehreren einzeleinheiten zusammengesetzte dosierungsform in tablettenform (i) |
-
1996
- 1996-04-26 SE SE9601598A patent/SE508669C2/sv not_active IP Right Cessation
-
1997
- 1997-03-29 SA SA97170759A patent/SA97170759B1/ar unknown
- 1997-04-14 ZA ZA9703153A patent/ZA973153B/xx unknown
- 1997-04-14 AR ARP970101488A patent/AR006640A1/es active IP Right Grant
- 1997-04-14 TW TW086104766A patent/TW420676B/zh not_active IP Right Cessation
- 1997-04-15 TN TNTNSN97068A patent/TNSN97068A1/fr unknown
- 1997-04-17 MA MA24558A patent/MA24143A1/fr unknown
- 1997-04-20 DZ DZ970056A patent/DZ2209A1/fr active
- 1997-04-21 HR HR970210A patent/HRP970210B1/xx not_active IP Right Cessation
- 1997-04-22 TR TR1998/02156T patent/TR199802156T2/xx unknown
- 1997-04-22 DK DK97921045T patent/DK0897386T3/da active
- 1997-04-22 SI SI9730402T patent/SI0897386T1/xx unknown
- 1997-04-22 US US08/860,825 patent/US6124464A/en not_active Expired - Lifetime
- 1997-04-22 WO PCT/SE1997/000674 patent/WO1997041114A1/en active IP Right Grant
- 1997-04-22 DE DE69714987T patent/DE69714987T2/de not_active Expired - Lifetime
- 1997-04-22 EP EP97921045A patent/EP0897386B1/en not_active Expired - Lifetime
- 1997-04-22 KR KR10-1998-0708556A patent/KR100468331B1/ko not_active IP Right Cessation
- 1997-04-22 CA CA002251636A patent/CA2251636C/en not_active Expired - Lifetime
- 1997-04-22 AT AT97921045T patent/ATE222904T1/de active
- 1997-04-22 UA UA98105319A patent/UA51699C2/uk unknown
- 1997-04-22 CZ CZ19983398A patent/CZ295067B6/cs not_active IP Right Cessation
- 1997-04-22 ID IDP971342A patent/ID16685A/id unknown
- 1997-04-22 CN CN97194114A patent/CN1100776C/zh not_active Expired - Fee Related
- 1997-04-22 PL PL97329683A patent/PL188824B1/pl not_active IP Right Cessation
- 1997-04-22 EE EE9800363A patent/EE03485B1/xx not_active IP Right Cessation
- 1997-04-22 IL IL12671697A patent/IL126716A/xx not_active IP Right Cessation
- 1997-04-22 EG EG32297A patent/EG23874A/xx active
- 1997-04-22 NZ NZ332154A patent/NZ332154A/en unknown
- 1997-04-22 BR BR9708829A patent/BR9708829A/pt not_active Application Discontinuation
- 1997-04-22 SK SK1407-98A patent/SK282752B6/sk not_active IP Right Cessation
- 1997-04-22 RU RU98121016/04A patent/RU2163238C2/ru not_active IP Right Cessation
- 1997-04-22 HU HU9901798A patent/HUP9901798A3/hu unknown
- 1997-04-22 JP JP53879697A patent/JP4233115B2/ja not_active Expired - Fee Related
- 1997-04-22 ES ES97921045T patent/ES2180981T3/es not_active Expired - Lifetime
- 1997-04-22 PT PT97921045T patent/PT897386E/pt unknown
- 1997-04-23 MY MYPI97001748A patent/MY119011A/en unknown
-
1998
- 1998-10-14 RS YUP-448/98A patent/RS49718B/sr unknown
- 1998-10-19 IS IS4872A patent/IS1984B/is unknown
- 1998-10-21 NO NO19984903A patent/NO318850B1/no not_active IP Right Cessation
-
1999
- 1999-05-07 HK HK99102051A patent/HK1016978A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS49718B (sr) | Postupak dobijanja magnezijumove soli supstituisanog heterocikličnog sulfinila | |
YU49475B (sh) | Postupak za sintezu supstituisanih sulfoksida | |
DE69428650D1 (de) | Dreisubstituirte phenylderivate als phosphodiesterasehemmer und verfahren zur ihre herstellung | |
DE69433594D1 (de) | Trisubstituierte phenyl-derivate, verfahren zu deren herstellung und deren verwendung als phosphodiesterase (typ iv) hemmstoffe | |
DE69322852D1 (de) | Drei-substituierte phenylderivate und verfahren zu ihrer herstellung | |
RU98121016A (ru) | Способ получения магниевой соли замещенного сульфинил-гетероцикла | |
ATE203015T1 (de) | Pyrazol-derivate, verfahren für ihre herstellung und sie enthaltende zusammensetzungen | |
DK0984955T3 (da) | Substituerede 2-(2,6-dioxopiperidin-3-yl)-phthalimider og 1-oxo-isoindoliner og fremgangsmåde til reduktion af TNF-alpha-niveauer | |
ME00108B (me) | DE RIVATI DIOKSAN-2-ALKILKARBAMATA, POSTUPAK ZA NJIHOVO DOBIJANJ E l PRIMENA ISTIH U TERAPEUTICIMA | |
PE20040512A1 (es) | Compuesto de pirazol-pirimidina anilina | |
DE69434041D1 (de) | Trisubstituierte phenyl-derivate, verfahren zu deren herstellung und deren verwendung als phosphodiesterase (typ iv) hemmstoffe | |
GB9625045D0 (en) | Parasiticidal compounds | |
UA37202C2 (uk) | Карбамати, проміжні сполуки, фунгіцидна композиція, спосіб боротьби з грибами | |
MEP25608A (en) | Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics | |
GB9423968D0 (en) | Resolution | |
MEP12608A (en) | Derivatives of n-[phenyl (pyrrolidine-2-yl) methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics | |
NO840861L (no) | Azol-derivater, fremgangsmaate for fremstilling derav og deres anvendelse son antifungale midler | |
BG104287A (en) | Halogensubstituted tetracyclic derivatives of tetrahydrofuran | |
PL267485A1 (en) | The method of manufacture of derivatives of 1,4-dihydropyridine | |
AR008287A1 (es) | Composicion herbicida que comprende compuestos de pirazol sustituidos y metodo de aplicacion de los mismos | |
ATE14014T1 (de) | Neue arylamin-derivate, verfahren zu deren herstellung und deren verwendung als mikrobizide. | |
ATE273981T1 (de) | Fungiizide 6-(trifluormethyl-phenyl)- triazolpyrimidine | |
MY109714A (en) | Process for preparing 8-chloroquinolone derivatives | |
MXPA04000371A (es) | 6- (2-tolil) - triazolopirimidinas substituidas. | |
TW350835B (en) | Process for preparing nitroaniline derivatives |